IL6 and COVID-19: In recent years, it has become clear that increased levels of cytokines such as IL-1, IL-2, IL-6, GMCSF, IFN-γ and TNF-α in COVID-19 patients can lead to cell death, tissue damage and fever, and can impact vascular physiology and coagulation [25].